Lufax Holding Shares Slide After Swinging to Loss, Posting Lower Revenue in 2Q
By Connor Hart
Shares of Lufax Holding fell after the company swung to a loss and posted lower revenue in the second quarter.
The stock dropped more than 12%, to $2.40, in early-afternoon trading Thursday. Shares are down more than 21% since the beginning of the year.
The Shanghai financial-services company after the bell on Wednesday reported a net loss of 730.0 million yuan ($102.2 million), or CNY0.69 a share, compared with a profit of CNY1 billion, or CNY0.84 a share, in last year's quarter.
Per American depository share, the company posted a loss of CNY1.38 compared with a profit of CNY1.68 in the same quarter last year.
Revenue fell nearly 36%, to CNY5.98 billion.
Technology-platform-based income fell 50%, in part dragged down by lower retail-credit service fees, caused by a decrease in loan balances. The company's total outstanding balance of loans fell to CNY235.2 billion in the recent quarter, from CNY426.4 billion last year.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
August 22, 2024 14:32 ET (18:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks